Next-generation nanobody discovery has increasingly moved toward protein-first approaches, bypassing the traditional limitations of genetic library biases. By analyzing antigen-enriched polyclonal pools directly from challenged serum, mass spectrometry uncovers high-affinity binders that survived in vivo maturation. This sophisticated workflow depends entirely on powerful computational...